Weekend reads: Science is “show me,” not “trust me;” pressure to publish survey data; what peer review misses

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured the University of Alabama’s request for 20 retractions of papers by one of its former researchers; a sturgeon researcher who’s up to 13 retractions for fake peer review; and what happens when researchers from several high-profile institutions can’t reproduce findings. Here’s what was happening elsewhere: Continue reading Weekend reads: Science is “show me,” not “trust me;” pressure to publish survey data; what peer review misses

Two years after student loses PhD, ORI concludes he committed misconduct

The U.S. Office of Research Integrity (ORI) announced today that a former graduate student committed research misconduct — nearly two years after his institution stripped him of his degree.

The ORI concluded that Shiladitya Sen committed misconduct in a PNAS paper (retracted six months ago), his PhD thesis, a poster presentation, and two grant applications to the National Institutes of Health (NIH). Sen has agreed not to seek federal funding for three years.

A spokesperson for The Ohio State University (OSU), where Sen was based, told us its investigation wrapped up in Spring 2016, and Sen’s PhD was revoked that June. It’s not clear why it took two years for the ORI to issue its own finding; the ORI did not immediately respond to requests for comment.

According to ORI’s notice, Sen:

Continue reading Two years after student loses PhD, ORI concludes he committed misconduct

U.S. government research watchdog pulls newsletter without explanation

The U.S. Office of Research Integrity has removed an issue of its quarterly newsletter, without including a public notice explaining why.

The main website for the newsletter — published since 1993 — is now missing the March 2017 edition.

A spokesperson for the agency told Retraction Watch: Continue reading U.S. government research watchdog pulls newsletter without explanation

Now-retracted chem paper’s problems “should have been noticed by the referees,” group says

Last year, chemist Marcus Tius at the University of Hawaii saw a paper describing the synthesis of some organic compounds, and was “struck by the implausibility” of the reported structures. So he joined up with some colleagues to try to replicate the data.

While Tius and his team were trying to repeat the experiment, however, in December 2017 the journal — Organic Letters — retracted the paper. The journal, published by the American Chemical Society, noted that the authors had not been able to produce crystal structures that confirm they had synthesized those compounds in particular. So Tius and his colleagues knew they couldn’t replicate the findings — but carried on their experiment anyway:

Continue reading Now-retracted chem paper’s problems “should have been noticed by the referees,” group says

University requests 20 retractions of cancer papers following probe

Santosh Katiyar

A university and medical center have requested a batch of retractions following an investigation that found 20 papers by a cancer researcher contained manipulated images.

The request, from University of Alabama, Birmingham (UAB) and Birmingham VA Medical Center, focuses on papers by Santosh Katiyar, who explored alternative approaches to treating skin cancer in animal models.

For more, see our story out today in The Scientist.

Continue reading University requests 20 retractions of cancer papers following probe

Caught Our Notice: A paper mistakenly ID’d a patient. Its retraction notice did, too. (Oops!)

What Caught Our Attention: Last year, a journal retracted a paper about a child who developed a rare complication related to the inherited disorder Gaucher Disease, after realizing it had inadvertently identified the child. It wasn’t an immediately obvious mistake — the authors listed the drugs the patient was taking, and in the case of one drug, there was only one child in the world taking it. For anyone in the know, that would make the child’s identity clear.

So retracting the paper makes sense — but publishing a retraction notice that spells out the issue in detail, including the name of the drug and the fact the patient was the only pediatric recipient, did not. So last month, the Journal of Pediatric Hematology/Oncology corrected the retraction notice, removing the name of the drug. (Phew.)

Continue reading Caught Our Notice: A paper mistakenly ID’d a patient. Its retraction notice did, too. (Oops!)

A distorted record on blood pressure drugs: Why one group is trying to clean up the literature

In 2015, a group of researchers based in Spain decided to write a review article on high blood pressure. But when they looked over eight articles co-authored by the same person, they noticed some undeniable similarities.

Over the last few years, Giuseppe Derosa, based at the University of Pavia in Italy, has racked up 10 retractions after journals determined he’d published the same material multiple times. But there’s much more to this story: The researchers in Spain (led by Luis Carlos Saiz of the Navarre Regional Health Service in Pamplona) kept digging into his publication record, and have since identified dozens of additional potential duplicates. Although the outside researchers alerted journals to the additional potentially problematic papers in 2015, most have not taken action; recently, two journals published by Taylor & Francis flagged 12 of Derosa’s articles, three of which they had been alerted about in 2015 by Saiz and colleagues.

Now, Saiz is telling his story — and why duplication of medical research matters:

Continue reading A distorted record on blood pressure drugs: Why one group is trying to clean up the literature

Sturgeon researcher nets 13 retractions for fake peer review

A fish scientist in Iran has now lost 13 papers about the properties of Sturgeon sperm — try saying that five times fast — and other ichthyological topics over concerns about faked peer review.

The three most recent retractions come from the Journal of Animal Physiology and Animal Nutrition. According to the notice:

Continue reading Sturgeon researcher nets 13 retractions for fake peer review

Caught Our Notice: A team from Harvard, Cornell, Cambridge, HHMI, and UCSF can’t reproduce a paper’s findings

What Caught Our Attention: Any time there’s an issue with a paper co-authored by researchers from such high-profile institutions as Harvard, Cornell, and the University of Cambridge, we take notice. In this case, the group — which included Laurie Glimcher, then-dean at Cornell, now president of the Dana-Farber Cancer Institute — chose to retract a 2013 paper from a Cell journal after learning they couldn’t reproduce some of the experiments. Continue reading Caught Our Notice: A team from Harvard, Cornell, Cambridge, HHMI, and UCSF can’t reproduce a paper’s findings

Weekend reads: How to get away with scientific fraud; what’s wrong with nutrition research; a second chance after misconduct

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured a collaboration with Undark looking at how scientists who commit fraud slip through the cracks, the story of a former cancer researcher who used her own blood 98 times instead of collecting that of study participants, and the puzzle of what took more than five years for papers by the world’s most prolific scientific fraudster to be retracted. Here’s what was happening elsewhere: Continue reading Weekend reads: How to get away with scientific fraud; what’s wrong with nutrition research; a second chance after misconduct